In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...

But since then, other routes of administration have become available. One of these alternative triptan routes is ...

Finally, the rates of absorption and time to peak plasma concentrations are comparable to IV administration, and are generally superior to subcutaneous or intramuscular routes. The use of IN ...

independent of the route of administration. In this study on intravenous administration, no short-term problems with regard to efficacy or tolerability were observed when patients were switched ...

Another type of misadministration is to use the wrong route of administration, which includes complete extravascular injections that can result in very high absorbed exposure at the injection site ...